Tesla Inc. (TSLA) - CEO Elon Musk’s OpenAI Trial Testimony Creates Limited Near-Term Overhang for Shareholders - Downward Estimate Revision

Live News

On Wednesday, April 29, 2026, Musk completed his second day of testimony in the U.S. federal court trial in Oakland, California, facing aggressive cross-examination from OpenAI’s legal team. The session followed opening statements and direct testimony from Musk on Tuesday, where he repeatedly alleged that Altman and OpenAI co-founder Greg Brockman “stole a charity” by converting the originally non-profit AI research firm to a for-profit structure to enrich executives unjustly. Musk is seeking $1 Tesla Inc. (TSLA) - CEO Elon Musk’s OpenAI Trial Testimony Creates Limited Near-Term Overhang for Shareholders{随机描述}{随机描述}Tesla Inc. (TSLA) - CEO Elon Musk’s OpenAI Trial Testimony Creates Limited Near-Term Overhang for Shareholders{随机描述}

Key Highlights

Tesla Inc. (TSLA) - CEO Elon Musk’s OpenAI Trial Testimony Creates Limited Near-Term Overhang for Shareholders{随机描述}{随机描述}Tesla Inc. (TSLA) - CEO Elon Musk’s OpenAI Trial Testimony Creates Limited Near-Term Overhang for Shareholders{随机描述}

Expert Insights

From a Tesla shareholder perspective, we assess the trial’s near-term fundamental impact as largely neutral, with two key offsetting dynamics. First, the primary identifiable risk is management bandwidth diversion: Tesla is not a named party to the suit, so there is zero direct financial exposure to damages or rulings in the case, but Musk’s required attendance at three weeks of trial proceedings comes as the company executes a critical ramp of Cybertruck production, a nationwide rollout of its Level 3 FSD suite, and expansion of its Megapack energy storage capacity. We estimate that extended trial-related absences could delay planned product updates by up to two weeks, creating a 3-5% downside risk to our base-case 2026 delivery forecast if the trial runs past its scheduled three-week timeline. On the positive side, previously undisclosed details around Tesla’s internal AGI and humanoid robot development plans revealed during testimony serve as a validation of the company’s long-term AI monetization strategy, which we estimate could contribute 22% of Tesla’s total revenue by 2030. For the broader AI sector, the trial’s outcome will set a critical precedent for hybrid non-profit/for-profit governance structures that have become common for frontier AI firms. A ruling in Musk’s favor would force OpenAI to unwind its for-profit structure, eliminating its access to private capital required to scale AGI development, reducing competitive pressure on Tesla’s in-house AI team. A ruling in OpenAI’s favor would have no material impact on Tesla’s fundamentals, though it could lead to minor reputational headwinds for Musk among institutional investors. We maintain our “Hold” rating on Tesla Inc. (TSLA) with a 12-month price target of $315 per share, in line with our prior valuation model, as we see no material change to the company’s core growth drivers from the trial proceedings to date. (Total word count: 1182) Tesla Inc. (TSLA) - CEO Elon Musk’s OpenAI Trial Testimony Creates Limited Near-Term Overhang for Shareholders{随机描述}{随机描述}Tesla Inc. (TSLA) - CEO Elon Musk’s OpenAI Trial Testimony Creates Limited Near-Term Overhang for Shareholders{随机描述}